Maat Pharma SA Financial Flexibility Index

Latest as of June 2025: -0.37x

Maat Pharma SA financial flexibility index. Maat Pharma SA (MAAT) has a Financial Flexibility Index of -0.37x as of June 2025. Free cash flow of €-15.17 Million (operating CF €-15.37 Million minus capex €202.00K) represents 0% of total liabilities (€40.58 Million).

Financial Flexibility Index

-0.37x
Free Cash Flow / Total Liabilities

Free Cash Flow

€-15.17 Million
Operating CF − Capex

Total Liabilities

€40.58 Million
EUR

Capital Expenditures

€202.00K
EUR

Financial Flexibility Index of Maat Pharma SA (2017–2024)

Financial flexibility index of Maat Pharma SA from 2017 to 2024. Historical Financial Flexibility Index trend for Maat Pharma SA across 8 annual periods. Explore debt repayment capacity of Maat Pharma SA to assess how comfortably operating cash covers total debt obligations.

Maat Pharma SA Financial Flexibility Index by Year (2017–2024)

Maat Pharma SA financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Maat Pharma SA. For the full cash flow conversion analysis, see MAAT operating cash flow.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2024 -0.76x €-21.29 Million €-22.04 Million €28.16 Million ▲ +3.4%
2023 -0.78x €-17.58 Million €-18.67 Million €22.46 Million ▼ -17.4%
2022 -0.67x €-11.94 Million €-12.61 Million €17.91 Million ▲ +17.1%
2021 -0.80x €-7.69 Million €-7.93 Million €9.56 Million ▼ -22.0%
2020 -0.66x €-5.50 Million €-5.81 Million €8.34 Million ▼ -71.7%
2019 -0.38x €-4.89 Million €-5.02 Million €12.73 Million ▲ +50.5%
2018 -0.78x €-3.58 Million €-3.87 Million €4.62 Million ▲ +13.5%
2017 -0.90x €-3.58 Million €-3.87 Million €3.99 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities